Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JCAP
JCAP logo

JCAP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jefferson Capital Inc (JCAP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
20.630
1 Day change
-0.77%
52 Week Range
23.800
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Jefferson Capital Inc (JCAP) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst ratings, and favorable long-term outlook outweigh the lack of recent news or trading signals. The current price of $19.95, combined with a potential upside to analyst price targets of $22-$28, makes this an attractive entry point.

Technical Analysis

The MACD is positively expanding, signaling bullish momentum. RSI is neutral at 69.118, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of $19.357, with resistance at $20.018 and support at $18.696.

Positive Catalysts

  • Strong financial performance in Q4 2025, including a 20.94% YoY revenue increase and 47.62% YoY EPS growth. Analysts highlight Jefferson's operational advantages, low leverage, and recent acquisition of Blue Stem as key drivers for long-term growth. Analyst price targets range from $22 to $28, suggesting significant upside potential.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from hedge funds or insiders. The stock lacks immediate momentum signals from AI Stock Picker or SwingMax.

Financial Performance

In Q4 2025, Jefferson Capital reported a 20.94% YoY increase in revenue to $101.55 million, a 26.21% YoY increase in net income to $34.02 million, and a 47.62% YoY increase in EPS to $0.62. These figures demonstrate strong growth and operational efficiency.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on JCAP, with multiple Outperform and Buy ratings. Price targets range from $22 to $28, indicating a potential upside of 10.3% to 40.4% from the current price. Analysts emphasize Jefferson's operational consistency, low leverage, and attractive valuation as key strengths.

Wall Street analysts forecast JCAP stock price to rise
4 Analyst Rating
Wall Street analysts forecast JCAP stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 20.790
sliders
Low
26
Averages
27.25
High
29
Current: 20.790
sliders
Low
26
Averages
27.25
High
29
Keefe Bruyette
Outperform
maintain
$28
AI Analysis
2026-03-30
Reason
Keefe Bruyette
Price Target
$28
AI Analysis
2026-03-30
maintain
Outperform
Reason
Jefferson Capital's management, led by CEO David Burton and CFO Christo Realov, highlighted opportunities for capital deployment, historical outperformance in recessions, low leverage supporting increased deployment, and structural operational advantages over peers, positioning the company well to deliver on a strong operating outlook, Keefe Bruyette tells investors in a research note. The firm, which has an Outperform rating and $28 price target on the shares, says the selloff creates an attractive entry point.
Raymond James
Outperform
downgrade
$25 -> $22
2026-03-13
Reason
Raymond James
Price Target
$25 -> $22
2026-03-13
downgrade
Outperform
Reason
Raymond James lowered the firm's price target on Jefferson Capital to $22 from $25 and keeps an Outperform rating on the shares. Despite reducing its price target, the firm continues to believe Jefferson's lower leverage, efficient collection model, heavy exposure to the U.S. market, which the firm believes is "currently more attractive," and recent acquisition of Blue Stem "position Jefferson Capital to outperform in the medium term."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JCAP
Unlock Now

People Also Watch